(Q34255293)

31 July 2017

1 reference

title

Topical corticosteroids in allergic rhinitis; effects on nasal inflammatory cells and nasal mucosa (English)

1 reference

31 July 2017

1 reference

Holm AF

1

1 reference

31 July 2017

Fokkens WJ

series ordinal

2

1 reference

31 July 2017

publication date

1 April 2001

1 reference

Clinical & Experimental Allergy

31 July 2017

published in

1 reference

31 July 2017

volume

31

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

529-535

1 reference

Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

Onset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

Triamcinolone acetonide Aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

Once daily treatment of mild to moderate hypertension with xipamid: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

Eye symptoms in patients taking propranolol and other hypotensive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

Inhaled and nasal corticosteroids: safety aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

Modulation of eosinophil chemotaxis by interleukin-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

Long-term effects of corticosteroid nasal spray on nasal inflammatory cells in patients with perennial allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01091.X

10.1046/J.1365-2222.2001.01091.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference